Cancer treatments, such as chemotherapy, radiation therapy, and targeted therapies, can inadvertently drive cancer evolution. These treatments can kill sensitive cancer cells but may leave behind resistant clones that can proliferate and lead to recurrence. This phenomenon underscores the importance of combination therapies to minimize the risk of resistance.
